Exhibit 10.1


  


[  ], 2021

 

Future Health ESG Corp.

8 The Green, Suite #12081

Dover, DE 19901

 

Re: Initial Public Offering

 

Ladies and Gentlemen:

 




This letter (this “Letter Agreement”)
is being delivered to you in accordance with the Underwriting Agreement (the “Underwriting Agreement”) entered
into or proposed to be entered into by and between Future Health ESG Corp., a Delaware corporation (the “Company”),
and Cantor Fitzgerald & Co., as the representative (“Representative”) of the several underwriters named
therein (each an “Underwriter” and collectively, the “Underwriters”), relating to
an underwritten initial public offering (the “Public Offering”), of up to 23,000,000 of the Company’s
units (including up to 3,000,000 units that may be purchased to cover the Underwriters’ option to purchase additional units, if
any) (the “Units”), each comprised of one share of common stock of the Company, par value $0.0001 per share
(“Common Stock”), and one-half of one redeemable warrant (each whole warrant, a “Warrant”).
Each Warrant entitles the holder thereof to purchase one share of Common Stock at a price of $11.50 per share, subject to adjustment.
The Units shall be sold in the Public Offering pursuant to a registration statement on Form S-1 and prospectus (the “Prospectus”)
filed by the Company with the Securities and Exchange Commission (the “Commission”). Certain capitalized terms
used herein are defined in paragraph 12 hereof.



 

In order to induce the Company and the Underwriters
to enter into the Underwriting Agreement and to proceed with the Public Offering and for other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged, the individuals and entities identified on the signature pages hereto as a Founder
(each such individual person or entity, a “Founder” and collectively, the “Founders”)
and Future Health ESG Associates 1, LLC (“FHA” and, each of the Founders and FHA is also
referred to as an “Insider” and collectively, the “Insiders”), each hereby agrees,
severally but not jointly, with the Company as follows:

 

1. Each
Insider agrees that if the Company seeks stockholder approval of a proposed Business Combination, then in connection with such
proposed Business Combination, it, he or she shall (i) vote any Shares owned by it, him or her in favor of any proposed Business
Combination (including any proposals recommended by the Company’s Board of Directors in connection with such Business
Combination) and (ii) not redeem any Shares owned by it, him or her in connection with such stockholder approval.


 



 

 




2.  
Each Insider hereby agrees that in the event that the Company fails to consummate a Business Combination within 15 months from
the closing of the Public Offering, or such later period approved by the Company’s stockholders in accordance with the
Company’s amended and restated certificate of incorporation, each Insider shall take all reasonable steps to cause the
Company to (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more
than ten (10) business days thereafter, subject to lawfully available funds therefor, redeem 100% of the shares of Common Stock
sold as part of the Units in the Public Offering (the “Offering Shares”), at a per share price, payable
in cash, equal to the aggregate amount then on deposit in the Trust Account, including interest (which interest shall be net of
taxes payable and less up to $100,000 of interest to pay dissolution expenses), divided by the number of then outstanding Offering
Shares, which redemption will completely extinguish all Public Stockholders’ rights as stockholders (including the right
to receive further liquidation distributions, if any) and (iii) as promptly as reasonably possible following such redemption,
subject to the approval of the Company’s remaining stockholders and the Company’s board of directors, dissolve and
liquidate, subject in each case to the Company’s obligations under Delaware law to provide for claims of creditors and
the other requirements of applicable law. Each Insider agrees to not propose any amendment to the Company’s amended
and restated certificate of incorporation (A) to modify the substance or timing of the Company’s obligation to allow redemption
as described in the Prospectus or (B) with respect to any other provision relating to stockholders’ rights or pre-initial
Business Combination activity, unless the Company provides its Public Stockholders with the opportunity to redeem their Offering
Shares upon approval of any such amendment at a per share price, payable in cash, equal to the aggregate amount then on deposit
in the Trust Account, including interest (which interest shall be net of taxes payable), divided by the number of then outstanding
Offering Shares.

 

Each Insider acknowledges that it,
he or she has no right, title, interest or claim of any kind in or to any monies held in the Trust Account or any other asset of the
Company as a result of any liquidation of the Company with respect to the Founder Shares held by it. Each Insider hereby further
waives, with respect to any Shares held by it, him or her, if any, any redemption rights it, he or she may have in connection with
(x) the consummation of a Business Combination, including, without limitation, any such rights available in the context of a
stockholder vote to approve such Business Combination or in the context of a tender offer made by the Company to purchase shares of
Common Stock and (y) a stockholder vote to approve an amendment to the Company’s amended and restated certificate of
incorporation (A) to modify the substance or timing of the Company’s obligation to allow redemptions as described in the
Prospectus or (B) with respect to any other provision relating to stockholders’ rights or pre-initial Business Combination
activity (although the Insiders shall be entitled to redemption and liquidation rights with respect to any Offering Shares it or
they hold if the Company fails to consummate a Business Combination within 15 months from the date of the closing of the Public
Offering).

 

3.   Notwithstanding the
provisions set forth in paragraphs 7(a) and (b) below, during the period commencing on the effective date of the Public Offering and
ending 180 days after such date, each Founder, FHA, and each Insider shall not, without the prior written consent of the
Representative, (i) offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract
to sell, grant any option, right or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, or file with,
or submit to, the Commission a registration statement under the Securities Act of 1933, as amended (the “Securities
Act”), relating to any Units, shares of Common Stock, Warrants or any securities convertible into, or exercisable, or
exchangeable for, any Units, shares of Common Stock, or Warrants, or publicly disclose the intention to undertake any of the
foregoing, or (ii) enter into any swap or other arrangement that transfers, in whole or in part, any of the economic consequences of
ownership of any Units, shares of Common Stock, or Warrants or any such other securities, whether any such transaction described in
clause (i) or (ii) above is to be settled by delivery of units or such other securities, in cash or otherwise, or (iii) publicly
announce any intention to effect any transaction specified in clause (i) or (ii). The provisions of this paragraph will not apply to
any transfer permitted under paragraph 7(c) hereof or (i) to permit a transfer of securities that is not for consideration and (ii)
the transferee has agreed in writing to be bound by the same terms described in this Letter Agreement to the extent and for the
duration that such terms remain in effect at the time of the transfer. 




2



 




4. In the event of the liquidation of the
Trust Account, FHA agrees to indemnify and hold harmless the Company against any and all loss, liability, claim, damage and expense whatsoever
(including, but not limited to, any and all legal or other expenses reasonably incurred in investigating, preparing or defending against
any litigation, whether pending or threatened, or any claim whatsoever) to which the Company may become subject as a result of any claim
by (i) any third party (other than the Company’s independent registered public accounting firm) for services rendered or products
sold to the Company or (ii) a prospective target business with which the Company has discussed entering into a transaction agreement (a
 “Target”); provided, however, that such indemnification of the Company by FHA shall apply only
to the extent necessary to ensure that such claims by a third party for services rendered (other than the Company’s independent
registered public accounting firm) or products sold to the Company or a Target do not reduce the amount of funds in the Trust Account
to below (i) $10.05 per Offering Share or (ii) such lesser amount per Offering Share held in the Trust Account as of the date of the liquidation
of the Trust Account due to reductions in the value of the trust assets as of the date of the liquidation of the Trust Account, in each
case, net of the amount of interest which may be withdrawn to pay taxes, except as to any claims by a third party who executed a waiver
of any and all rights to seek access to the Trust Account and except as to any claims under the Company’s indemnity of the Underwriters
against certain liabilities, including liabilities under the Securities Act. In the event that any such executed waiver is deemed to be
unenforceable against such third party, FHA shall not be responsible to the extent of any liability for such third-party claims. FHA shall
have the right to defend against any such claim with counsel of its choice reasonably satisfactory to the Company if, within 15 days following
written receipt of notice of the claim to FHA, FHA notifies the Company in writing that it shall undertake such defense.


 

5. (a) To the extent that the
Underwriters do not exercise their option to purchase up to an additional 3,000,000 Units within 45 days from the date of the
Prospectus (and as further described in the Prospectus), each Founder agrees that it shall forfeit, at no cost, a number of Founder
Shares equal to 750,000, multiplied by (i) a fraction, (x) the numerator of which is 3,000,000 minus the number of Units purchased
by the Underwriters upon the exercise of their option to purchase additional Units and (y) the denominator of which is 3,000,000,
multiplied by (ii) a fraction (x) the numerator of which is the number of Founder Shares purchased by it, her or him and (y) the
denominator of which is the aggregate number of Founder Shares held by all Founders. All references in this Letter Agreement to
Founder Shares of the Company being forfeited shall take effect as a contribution of such Founder Shares to the Company’s
capital as a matter of Delaware law. The forfeiture will be adjusted on a pro rata basis among each Founder to the extent that the
option to purchase additional Units is not exercised in full by the Underwriters so that the number of Founder Shares will equal an
aggregate of 20.0% of the Company’s issued and outstanding Shares after the Public Offering. The Initial Stockholders further
agree that to the extent that the size of the Public Offering is increased or decreased, the Company will effect a capitalization or
stock repurchase or redemption, as applicable, immediately prior to the consummation of the Public Offering in such amount as to
maintain the number of Founder Shares at 20.0% of the Company’s issued and outstanding Shares upon the consummation of the
Public Offering. In connection with such increase or decrease in the size of the Public Offering, then (A) the references to
3,000,000 and 750,000 in the numerator and denominator of the formula in the first sentence of this paragraph shall be changed to a
number equal to 15.0% of the number of shares of Common Stock included in the Units issued in the Public Offering and 15.0% of the
aggregate number of Founder Shares (assuming no exercise of the Underwriters’ over-allotment option), respectively.





3



 



6. Each Insider hereby agrees and acknowledges that: (i) the Underwriters and the Company would be irreparably injured in the event of a breach by such Insider of its, his or her obligations under paragraphs 1, 2, 3, 4, 5, 7(a), 7(b), and 9 of this Letter Agreement (ii) monetary damages may not be an adequate remedy for such breach and (iii) the non-breaching party shall be entitled to seek injunctive relief, in addition to any other remedy that such party may have in law or in equity, in the event of such breach.

 

7. (a) Each Insider agrees that it, he or she shall not Transfer (as defined below) any Founder Shares until the earlier of (A) one year after the completion of the Company’s initial Business Combination and (B) subsequent to the Business Combination, (x) the date on which the Company completes a liquidation, merger, stock exchange, reorganization or other similar transaction that results in all of the Public Stockholders having the right to exchange their shares of Common Stock for cash, securities or other property or (y) if the last reported sale price of the Common Stock equals or exceeds $12.00 per share (as adjusted for stock splits, stock dividends, reorganizations, recapitalizations and the like) for any 20 trading days within any 30-trading day period commencing after the Company’s initial Business Combination (the “Founder Shares Lock-Up Period”).

 

(b) Each Insider agrees that
it, he or she shall not Transfer any Private Placement Warrants or Underlying Shares until 30 days after the completion of a
Business Combination (the “Private Placement Warrants Lock-Up Period”, together with the Founder Shares
Lock-Up Period, the “Lock-Up Periods”).

 

(c) Notwithstanding the provisions set forth in paragraphs 7(a) and (b), Transfers of the Founder Shares, the Private Placement Warrants and the Underlying Shares or the Founder Shares and that are held by any Insider or any of their permitted transferees (that have complied with this paragraph 7(c)), are permitted (a) to the Company’s officers or directors, any affiliates or family members of any of the Company’s officers or directors, any members of the Founders, or any affiliates of the Founders, (b) in the case of an individual, by gift to a member of the individual’s immediate family or to a trust, the beneficiary of which is a member of the individual’s immediate family or an affiliate of such person, or to a charitable organization; (c) in the case of an individual, by virtue of laws of descent and distribution upon death of the individual; (d) in the case of an individual, pursuant to a qualified domestic relations order; (e) by private sales or transfers made in connection with the consummation of the Company’s Business Combination at prices no greater than the price at which the securities were originally purchased; (f) in the event of the Company’s liquidation prior to the Company’s completion of an initial Business Combination; (g) by virtue of the laws of Delaware or FHA’s or any Founder’s limited liability company, partnership or trust agreement, as amended, or other organizational documents upon dissolution of FHA or a Founder; or (h) in the event of the Company’s completion of a liquidation, merger, stock exchange, reorganization or other similar transaction which results in all of the Public Stockholders having the right to exchange their Common Stock for cash, securities or other property subsequent to the Company’s completion of an initial Business Combination; provided, however, that in the case of clauses (a) through (e), these permitted transferees must enter into a written agreement with the Company agreeing to be bound by the transfer restrictions and other applicable restrictions in this Letter Agreement.

 

8. Each Insider represents and warrants that it, he or she has never been suspended or expelled from membership in any securities or commodities exchange or association or had a securities or commodities license or registration denied, suspended or revoked. Each Insider’s biographical information furnished to the Company, if any (including any such information included in the Prospectus), is true and accurate in all respects and does not omit any material information with respect to such Insider’s background. Each Insider’s questionnaire furnished to the Company, if any, is true and accurate in all respects. Each Insider represents and warrants that: it is not subject to or a respondent in any legal action for, any injunction, cease-and-desist order or order or stipulation to desist or refrain from any act or practice relating to the offering of securities in any jurisdiction; it has never been convicted of, or pleaded guilty to, any crime (i) involving fraud, (ii) relating to any financial transaction or handling of funds of another person, or (iii) pertaining to any dealings in any securities and it is not currently a defendant in any such criminal proceeding.





4



 



9. Except as disclosed in, or as expressly contemplated by, the Prospectus, neither any Insider nor any affiliate of any Insider, nor any director or officer of the Company, shall receive from the Company any finder’s fee, reimbursement, consulting fee, monies in respect of any repayment of a loan or other compensation prior to, or in connection with any services rendered in order to effectuate the consummation of the Company’s initial Business Combination (regardless of the type of transaction that it is).

 

10.           Each Insider has full right and power, without violating any agreement to which it is bound (including, without limitation, any non-competition or non-solicitation agreement with any employer or former employer), to enter into this Letter Agreement and, as applicable, to serve as an officer and/or a director on the board of directors of the Company and, if applicable, hereby consents to being named in the Prospectus as an officer and/or a director of the Company.

 

11.           Each Insider acknowledges that he, she or it may, from time to time, receive material non-public information relating to the Company, including with respect to proposed transactions, and is cautioned not to trade in the Company’s securities while in possession of non-public information relating to the Company.

 

12.           As
used herein, (i) “Business Combination” shall mean a merger, capital stock exchange, asset acquisition,
stock purchase, reorganization or similar business combination, involving the Company and one or more target businesses; (ii)
 “Shares” shall mean, collectively, the Common Stock, the Founder Shares and the Underlying Shares; (iii)
 “Founder Shares” shall mean the 5,750,000 shares of Common Stock issued and outstanding immediately prior
to the consummation of the Public Offering; (iv) “Initial Stockholders” shall mean the Founders, FHA and
any Insider that holds Founder Shares; (v) “Private Placement Warrants” shall mean the 6,375,000 warrants
of the Company (or 6,975,000 warrants if the over-allotment option is exercised in full) that the Founders have agreed to purchase
for an aggregate purchase price of $6,375,000 in the aggregate (or $6,975,000 if the over-allotment option is exercised in full), or
$1.00 per warrant, in a private placement that shall occur substantially concurrently with the consummation of the Public Offering;
(vii) “Public Stockholders” shall mean the holders of securities issued in the Public Offering; (viii)
 “Trust Account” shall mean the trust fund into which a portion of the net proceeds of the Public Offering
shall be deposited;  (ix) “Transfer” shall mean the (a) sale or assignment of, offer to sell, contract
or agreement to sell, hypothecate, pledge, grant of any option to purchase or otherwise dispose of or agreement to dispose of,
directly or indirectly, or establishment or increase of a put equivalent position or liquidation with respect to or decrease of a
call equivalent position within the meaning of Section 16 of the Securities Exchange Act of 1934, as amended, and the rules and
regulations of the Commission promulgated thereunder with respect to, any security, (b) entry into any swap or other arrangement
that transfers to another, in whole or in part, any of the economic consequences of ownership of any security, whether any such
transaction is to be settled by delivery of such securities, in cash or otherwise, or (c) public announcement of any intention to
effect any transaction specified in clause (a) or (b) herein; and (x) “Underlying Shares” shall mean
shares of Common Stock issuable upon exercise of the Private Placement Warrants.


 

13.           This Letter Agreement constitutes the entire agreement and understanding of the parties hereto in respect of the subject matter hereof and supersedes all prior understandings, agreements, or representations by or among the parties hereto, written or oral, to the extent they relate in any way to the subject matter hereof or the transactions contemplated hereby. This Letter Agreement may not be changed, amended, modified or waived (other than to correct a typographical error) as to any particular provision, except by a written instrument executed by (1) each Insider and each Founder that is the subject of any such change, amendment modification or waiver and (2) the Company.





5



 




14.           No party hereto may assign either this Letter Agreement or any of its rights, interests, or obligations hereunder without the prior written consent of the other parties. Any purported assignment in violation of this paragraph shall be void and ineffectual and shall not operate to transfer or assign any interest or title to the purported assignee. This Letter Agreement shall be binding on each Insider and their respective successors, heirs and assigns and permitted transferees.

 

15.           Nothing in this Letter Agreement shall be construed to confer upon, or give to, any person or corporation other than the parties hereto any right, remedy or claim under or by reason of this Letter Agreement or of any covenant, condition, stipulation, promise or agreement hereof. All covenants, conditions, stipulations, promises and agreements contained in this Letter Agreement shall be for the sole and exclusive benefit of the parties hereto and their successors, heirs, personal representatives and assigns and permitted transferees; provided, however, that the Underwriters shall benefit from the provisions set forth in paragraph 3, which such paragraphs shall not be amended or modified without the written consent of the Representative.

 

16.           This Letter Agreement may be executed in any number of original or facsimile counterparts and each of such counterparts shall for all purposes be deemed to be an original, and all such counterparts shall together constitute but one and the same instrument.

 

17.           This Letter Agreement shall be deemed severable, and the invalidity or unenforceability of any term or provision hereof shall not affect the validity or enforceability of this Letter Agreement or of any other term or provision hereof. Furthermore, in lieu of any such invalid or unenforceable term or provision, the parties hereto intend that there shall be added as a part of this Letter Agreement a provision as similar in terms to such invalid or unenforceable provision as may be possible and be valid and enforceable.

 

18.           This Letter Agreement shall be governed by and construed and enforced in accordance with the laws of the State of New York. The parties hereto (i) all agree that any action, proceeding, claim or dispute arising out of, or relating in any way to, this Letter Agreement shall be brought and enforced in the courts of New York City, in the State of New York, and irrevocably submit to such jurisdiction and venue, which jurisdiction and venue shall be exclusive and (ii) waive any objection to such exclusive jurisdiction and venue or that such courts represent an inconvenient forum.

 

19.           Any notice, consent or request to be given in connection with any of the terms or provisions of this Letter Agreement shall be in writing and shall be sent by express mail or similar private courier service, by certified mail (return receipt requested), by hand delivery or facsimile or other electronic transmission.

 

20.           Each party hereto shall not be liable for any breaches or misrepresentations contained in this Letter Agreement by any other party to this Letter Agreement, and no party shall be liable or responsible for the obligations of another party, including, without limitation, indemnification obligations and notice obligations.

 

21.          This Letter Agreement shall terminate on the earlier of (i) the expiration of the Lock-Up Periods and (ii) the liquidation of the Company; provided, however, that this Letter Agreement shall earlier terminate in the event that the Public Offering is not consummated and closed by [ ]; provided further that paragraph 4 of this Letter Agreement shall survive such liquidation.

 

[Signature Page Follows]





6



 



	 

	Sincerely,


	 

	 


	 

	FOUNDERS:


	 

	 

	 


	 

	BEA
HOLDINGS, LLC


	 

	 

	 


	 

	By:

	 


	 

	Name: Bradley
A. Bostic


	 

	Title: Manager


	 

	 

	 


	 

	M2
ENTERPRISES HOLDINGS, LLC


	 

	 

	 


	 

	By:

	 


	 

	Name:

	Travis
A. Morgan


	 

	Title:

	Manager


	 

	 


	 

	HC1.COM,
INC


	 

	 

	 


	 

	By:

	 


	 

	Name:

	Chris
Brown


	 

	Title:

	Chief
Operating Officer


	 

	 


	 

	R.
Mark Lubbers


	 

	 


	 

	Dr.
F. John Mills


	 

	 


	 

	Dr.
Nancy L. Snyderman




 


 [Signature Page to Letter Agreement]





 

 



	
 

	
FHA:


	
 

	
 

	
 


	
 

	
FUTURE HEALTH ASSOCIATES 1, LLC


	
 

	
 

	
 


	
 

	
By:

	
 


	
 

	
Name:

	
Travis A. Morgan


	
 

	
Title:

	
Manager




 

  [Signature Page to Letter Agreement]




 

 




	
Acknowledged and Agreed: 


	
 


	
FUTURE HEALTH ESG CORP.


	
 


	
 


	
By:

	
 

	
 


	
 

	
Name: Bradley A. Bostic

	
 


	
 

	
Title: Chief Executive Officer

	
 




 

[Signature Page to Letter Agreement]